In one study, patients with CALR mutations had a significantly higher incidence of transformation from ET to MF than those with JAK2 mutations.8 In other studies,9,22 there was not a significant difference in myelofibrotic transformation between these two groups. The gene discussed is CALR; the disease is essential thrombocythemia.